相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Severity of Pneumococcal Pneumonia Associated With Genomic Bacterial Load
Jordi Rello et al.
CHEST (2009)
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia
Daren K. Heyland et al.
CRITICAL CARE MEDICINE (2008)
Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
Glenn A. Pankuch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis
M. Paul et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
Liat Vidal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia:: An observational, multicenter study comparing monotherapy with combination antibiotic therapy
Jose Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2007)
Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia
R. Chokshi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock
Alejandro Rodriguez et al.
CRITICAL CARE MEDICINE (2007)
Addition of a macrolide to a β-lactam in bacteremic pneumococcal pneumonia
R. Dwyer et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock:: Association with serum lactate and inflammatory cytokine levels
A Kumar et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]
Pierre Damas et al.
CRITICAL CARE (2006)
Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis
S Harbarth et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone
EG Vázquez et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Nonantimicrobial effects of antibacterial agents
TR Pasquale et al.
CLINICAL INFECTIOUS DISEASES (2005)
EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units
C Brun-Buisson et al.
INTENSIVE CARE MEDICINE (2004)
beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials
M Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
LM Baddour et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
N Safdar et al.
LANCET INFECTIOUS DISEASES (2004)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease
R Ovstebo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Cellular and molecular effects of macrolides on leukocyte function
MT Labro
CURRENT PHARMACEUTICAL DESIGN (2004)
Controlling the risk of spurious findings from meta-regression
JPT Higgins et al.
STATISTICS IN MEDICINE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia
E Chamot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia:: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species
BN Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Community-acquired bloodstream infection in critically ill adult patients:: Impact of shock and inappropriate antibiotic therapy on survival
J Vallés et al.
CHEST (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia
RA Fowler et al.
CHEST (2003)
Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
JA Martínez et al.
CLINICAL INFECTIOUS DISEASES (2003)
Risk and the efficacy of antiinflammatory agents - Retrospective and confirmatory studies of sepsis
PQ Eichacker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
How should meta-regression analyses be undertaken and interpreted?
SG Thompson et al.
STATISTICS IN MEDICINE (2002)
Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period
BN Kim et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2002)
Advanced methods in meta-analysis: multivariate approach and meta-regression
HC van Houwelingen et al.
STATISTICS IN MEDICINE (2002)
Pharmacokinetic-pharmacodynamic modeling of the inhibitory effect of erythromycin on tumour necrosis factor-α and interleukin-6 production
HJ Guchelaar et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2001)
Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia
GW Waterer et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
E Gradelski et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Monotherapy versus combination therapy for bacterial infections
E Bouza et al.
MEDICAL CLINICS OF NORTH AMERICA (2000)
Antibiotic synergy and antagonism
JF Acar
MEDICAL CLINICS OF NORTH AMERICA (2000)
Interference of antibacterial agents with phagocyte functions: Immunomodulation or immuno-fairy tales?
MT Labro
CLINICAL MICROBIOLOGY REVIEWS (2000)
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial
H Dupont et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia
WC Ko et al.
JOURNAL OF INFECTION (2000)
Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: A survey of nonteaching US community hospitals
V Dudas et al.
ANNALS OF PHARMACOTHERAPY (2000)
Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options
CA Gogos et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
